A new method for measuring inhibition of platelet function by nonsteroidal antiinflammatory drugs
- 1 April 2002
- journal article
- Published by Elsevier in Journal of Laboratory and Clinical Medicine
- Vol. 139 (4), 227-233
- https://doi.org/10.1067/mlc.2002.121855
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Platelet Glycoprotein IIb/IIIa Receptor Blockade and Low-Dose Heparin during Percutaneous Coronary RevascularizationNew England Journal of Medicine, 1997
- Effects of Nonsteroidal Antiinflammatory Drugs on Platelet Function and Systemic HemostasisThe Journal of Clinical Pharmacology, 1995
- Aspirin, platelets, and thrombosis: theory and practiceBlood, 1994
- Collaborative overview of randomised trials of antiplatelet therapy - III: Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patientsBMJ, 1994
- Collaborative overview of randomised trials of antiplatelet therapy - II: Maintenance of vascular graft or arterial patency by antiplatelet therapyBMJ, 1994
- Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patientsBMJ, 1994
- Aspirin versus heparin to prevent myocardial infarction during the acute phase of unstable angina.Circulation, 1993
- Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery diseaseThe Lancet, 1990
- Aspirin, Heparin, or Both to Treat Acute Unstable AnginaNew England Journal of Medicine, 1988
- Protective Effects of Aspirin against Acute Myocardial Infarction and Death in Men with Unstable AnginaNew England Journal of Medicine, 1983